{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T04:53:45Z","timestamp":1779166425109,"version":"3.51.4"},"reference-count":57,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,22]],"date-time":"2023-03-22T00:00:00Z","timestamp":1679443200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000048","name":"American Cancer Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000048","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 CA157429"],"award-info":[{"award-number":["R01 CA157429"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 CA256893"],"award-info":[{"award-number":["R01 CA256893"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 CA196634"],"award-info":[{"award-number":["R01 CA196634"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 CA264652"],"award-info":[{"award-number":["R01 CA264652"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["#IRG 19-140-31"],"award-info":[{"award-number":["#IRG 19-140-31"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015087","name":"Markey Cancer Center, University of Kentucky","doi-asserted-by":"publisher","award":["P30CA177558"],"award-info":[{"award-number":["P30CA177558"]}],"id":[{"id":"10.13039\/100015087","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports Medicine"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.xcrm.2023.101015","type":"journal-article","created":{"date-parts":[[2023,4,18]],"date-time":"2023-04-18T10:39:25Z","timestamp":1681814365000},"page":"101015","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["A kinome-wide CRISPR screen identifies CK1\u03b1 as a target to overcome enzalutamide resistance of prostate cancer"],"prefix":"10.1016","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9676-1538","authenticated-orcid":false,"given":"Jinghui","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daheng","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katelyn M.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shan","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Derek B.","family":"Allison","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanquan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiongsi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinyi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chaohao","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoqi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.xcrm.2023.101015_bib1","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of Incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA A Cancer J. Clin."},{"key":"10.1016\/j.xcrm.2023.101015_bib2","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.trecan.2020.04.010","article-title":"Advanced prostate cancer: treatment advances and future directions","volume":"6","author":"Swami","year":"2020","journal-title":"Trends Cancer"},{"key":"10.1016\/j.xcrm.2023.101015_bib3","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1056\/NEJMoa1903835","article-title":"Enzalutamide with standard first-line therapy in metastatic prostate cancer","volume":"381","author":"Davis","year":"2019","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.xcrm.2023.101015_bib4","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1056\/NEJMoa1800536","article-title":"Enzalutamide in men with nonmetastatic, castration-resistant prostate cancer","volume":"378","author":"Hussain","year":"2018","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.xcrm.2023.101015_bib5","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/nrc4016","article-title":"Emerging mechanisms of resistance to androgen receptor inhibitors in prostate cancer","volume":"15","author":"Watson","year":"2015","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.xcrm.2023.101015_bib6","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/j.cell.2013.11.012","article-title":"Glucocorticoid receptor confers resistance to antiandrogens by bypassing androgen receptor blockade","volume":"155","author":"Arora","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2023.101015_bib7","doi-asserted-by":"crossref","first-page":"12315","DOI":"10.1073\/pnas.1922207117","article-title":"Transcriptional profiling identifies an androgen receptor activity-low, stemness program associated with enzalutamide resistance","volume":"117","author":"Alumkal","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2023.101015_bib8","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nm.4045","article-title":"Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer","volume":"22","author":"Beltran","year":"2016","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2023.101015_bib9","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1126\/science.1247005","article-title":"Genome-scale CRISPR-Cas9 knockout screening in human cells","volume":"343","author":"Shalem","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2023.101015_bib10","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/s41588-019-0554-0","article-title":"ARID1A determines luminal identity and therapeutic response in estrogen-receptor-positive breast cancer","volume":"52","author":"Xu","year":"2020","journal-title":"Nat. Genet."},{"key":"10.1016\/j.xcrm.2023.101015_bib11","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12964-018-0236-z","article-title":"Casein kinase 1alpha: biological mechanisms and theranostic potential","volume":"16","author":"Jiang","year":"2018","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.xcrm.2023.101015_bib12","doi-asserted-by":"crossref","first-page":"96","DOI":"10.3389\/fonc.2014.00096","article-title":"The CK1 family: contribution to cellular stress response and its role in carcinogenesis","volume":"4","author":"Knippschild","year":"2014","journal-title":"Front. Oncol."},{"key":"10.1016\/j.xcrm.2023.101015_bib13","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/nature14610","article-title":"Lenalidomide induces ubiquitination and degradation of CK1alpha in del(5q) MDS","volume":"523","author":"Kr\u00f6nke","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2023.101015_bib14","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s12885-018-4019-0","article-title":"CK1alpha overexpression correlates with poor survival in colorectal cancer","volume":"18","author":"Richter","year":"2018","journal-title":"BMC Cancer"},{"key":"10.1016\/j.xcrm.2023.101015_bib15","doi-asserted-by":"crossref","first-page":"4937","DOI":"10.1158\/0008-5472.CAN-15-1113","article-title":"Inhibition of casein kinase 1 alpha prevents acquired drug resistance to erlotinib in EGFR-mutant non-small cell lung cancer","volume":"75","author":"Lantermann","year":"2015","journal-title":"Cancer Res."},{"key":"10.1016\/j.xcrm.2023.101015_bib16","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/s41573-021-00195-4","article-title":"Kinase drug discovery 20 years after imatinib: progress and future directions","volume":"20","author":"Cohen","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.xcrm.2023.101015_bib17","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1038\/s41596-018-0113-7","article-title":"Integrative analysis of pooled CRISPR genetic screens using MAGeCKFlute","volume":"14","author":"Wang","year":"2019","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.xcrm.2023.101015_bib18","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/j.cell.2015.11.015","article-title":"High-resolution CRISPR screens reveal fitness genes and genotype-specific cancer liabilities","volume":"163","author":"Hart","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2023.101015_bib19","doi-asserted-by":"crossref","first-page":"6635","DOI":"10.1158\/0008-5472.CAN-14-1916","article-title":"Plk1 inhibition enhances the efficacy of androgen signaling blockade in castration-resistant prostate cancer","volume":"74","author":"Zhang","year":"2014","journal-title":"Cancer Res."},{"key":"10.1016\/j.xcrm.2023.101015_bib20","doi-asserted-by":"crossref","first-page":"2744","DOI":"10.1158\/1078-0432.CCR-15-2119","article-title":"Cotargeting androgen receptor splice variants and mTOR signaling pathway for the treatment of castration-resistant prostate cancer","volume":"22","author":"Kato","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.xcrm.2023.101015_bib21","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.eururo.2019.05.042","article-title":"Durable response of enzalutamide-resistant prostate cancer to supraphysiological testosterone is associated with a multifaceted growth suppression and Impaired DNA damage response transcriptomic program in patient-derived xenografts","volume":"77","author":"Lam","year":"2020","journal-title":"Eur. Urol."},{"key":"10.1016\/j.xcrm.2023.101015_bib22","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21218273","article-title":"Targeting DNA damage response in prostate and breast cancer","volume":"21","author":"Wengner","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.xcrm.2023.101015_bib23","doi-asserted-by":"crossref","first-page":"11428","DOI":"10.1073\/pnas.1902651116","article-title":"Genomic correlates of clinical outcome in advanced prostate cancer","volume":"116","author":"Abida","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2023.101015_bib24","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1158\/1541-7786.MCR-20-0975","article-title":"Circulating tumor cell genomic evolution and hormone therapy outcomes in men with metastatic castration-resistant prostate cancer","volume":"19","author":"Gupta","year":"2021","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.xcrm.2023.101015_bib25","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aam7479","article-title":"Androgen receptor inhibitor-induced \"BRCAness\" and PARP inhibition are synthetically lethal for castration-resistant prostate cancer","volume":"10","author":"Li","year":"2017","journal-title":"Sci. Signal."},{"key":"10.1016\/j.xcrm.2023.101015_bib26","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.cell.2018.07.045","article-title":"Small molecules Co-targeting CKIalpha and the transcriptional kinases CDK7\/9 control AML in preclinical models","volume":"175","author":"Minzel","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2023.101015_bib27","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1177\/1947601910379132","article-title":"MYC and prostate cancer","volume":"1","author":"Koh","year":"2010","journal-title":"Genes Cancer"},{"key":"10.1016\/j.xcrm.2023.101015_bib28","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1101\/gad.230302","article-title":"Axin-mediated CKI phosphorylation of beta-catenin at Ser 45: a molecular switch for the Wnt pathway","volume":"16","author":"Amit","year":"2002","journal-title":"Genes Dev."},{"key":"10.1016\/j.xcrm.2023.101015_bib29","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0092-8674(02)00685-2","article-title":"Control of beta-catenin phosphorylation\/degradation by a dual-kinase mechanism","volume":"108","author":"Liu","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2023.101015_bib30","doi-asserted-by":"crossref","first-page":"3147","DOI":"10.1158\/0008-5472.CAN-17-3006","article-title":"Inhibition of the wnt\/beta-catenin pathway overcomes resistance to enzalutamide in castration-resistant prostate cancer","volume":"78","author":"Zhang","year":"2018","journal-title":"Cancer Res."},{"key":"10.1016\/j.xcrm.2023.101015_bib31","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/nature09673","article-title":"CKIalpha ablation highlights a critical role for p53 in invasiveness control","volume":"470","author":"Elyada","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2023.101015_bib32","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.ccr.2013.06.005","article-title":"A senescence-inflammatory switch from cancer-inhibitory to cancer-promoting mechanism","volume":"24","author":"Pribluda","year":"2013","journal-title":"Cancer Cell"},{"key":"10.1016\/j.xcrm.2023.101015_bib33","doi-asserted-by":"crossref","first-page":"5634","DOI":"10.1093\/nar\/gkz286","article-title":"A novel CRISPR-engineered prostate cancer cell line defines the AR-V transcriptome and identifies PARP inhibitor sensitivities","volume":"47","author":"Kounatidou","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.xcrm.2023.101015_bib34","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1158\/2159-8290.CD-13-0172","article-title":"Androgen receptor signaling regulates DNA repair in prostate cancers","volume":"3","author":"Polkinghorn","year":"2013","journal-title":"Cancer Discov."},{"key":"10.1016\/j.xcrm.2023.101015_bib35","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1016\/j.celrep.2017.01.072","article-title":"Targeting DNA damage response in prostate cancer by inhibiting androgen receptor-CDC6-ATR-chk1 signaling","volume":"18","author":"Karanika","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.xcrm.2023.101015_bib36","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.molcel.2017.05.015","article-title":"ATM, ATR, and DNA-PK: the trinity at the heart of the DNA damage response","volume":"66","author":"Blackford","year":"2017","journal-title":"Mol. Cell."},{"key":"10.1016\/j.xcrm.2023.101015_bib37","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3389\/fmolb.2020.00024","article-title":"Studying DNA double-strand break repair: an ever-growing toolbox","volume":"7","author":"V\u00edtor","year":"2020","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.xcrm.2023.101015_bib38","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0092-8674(00)80416-X","article-title":"DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2","volume":"91","author":"Shieh","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2023.101015_bib39","first-page":"201","article-title":"RB1, cancer lineage plasticity, and therapeutic resistance","volume":"6","author":"Zhang","year":"2022","journal-title":"Annu. Rev. Cell Biol."},{"key":"10.1016\/j.xcrm.2023.101015_bib40","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1126\/science.aah4307","article-title":"SOX2 promotes lineage plasticity and antiandrogen resistance in TP53- and RB1-deficient prostate cancer","volume":"355","author":"Mu","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2023.101015_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/nm.4341","article-title":"Biology and evolution of poorly differentiated neuroendocrine tumors","volume":"23","author":"Rickman","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2023.101015_bib42","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/nmeth.3047","article-title":"Improved vectors and genome-wide libraries for CRISPR screening","volume":"11","author":"Sanjana","year":"2014","journal-title":"Nat. Methods"},{"key":"10.1016\/j.xcrm.2023.101015_bib43","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.stem.2016.10.002","article-title":"The p53 family coordinates Wnt and nodal inputs in mesendodermal differentiation of embryonic stem cells","volume":"20","author":"Wang","year":"2017","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.xcrm.2023.101015_bib44","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms11987","article-title":"Integrated genetic and pharmacologic interrogation of rare cancers","volume":"7","author":"Hong","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2023.101015_bib45","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1126\/science.281.5383.1677","article-title":"Activation of the ATM kinase by ionizing radiation and phosphorylation of p53","volume":"281","author":"Canman","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2023.101015_bib46","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/nbt.3437","article-title":"Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9","volume":"34","author":"Doench","year":"2016","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.xcrm.2023.101015_bib47","doi-asserted-by":"crossref","first-page":"498","DOI":"10.4161\/cc.8.3.7701","article-title":"Single-vector inducible lentiviral RNAi system for oncology target validation","volume":"8","author":"Wiederschain","year":"2009","journal-title":"Cell Cycle"},{"key":"10.1016\/j.xcrm.2023.101015_bib48","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1182\/blood-2018-01-828418","article-title":"CK1alpha and IRF4 are essential and independent effectors of immunomodulatory drugs in primary effusion lymphoma","volume":"132","author":"Patil","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.xcrm.2023.101015_bib49","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1261\/rna.2192803","article-title":"Lentivirus-delivered stable gene silencing by RNAi in primary cells","volume":"9","author":"Stewart","year":"2003","journal-title":"RNA"},{"key":"10.1016\/j.xcrm.2023.101015_bib50","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1186\/s13059-015-0843-6","article-title":"Quality control, modeling, and visualization of CRISPR screens with MAGeCK-VISPR","volume":"16","author":"Li","year":"2015","journal-title":"Genome Biol."},{"key":"10.1016\/j.xcrm.2023.101015_bib51","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1093\/nar\/gkv007","article-title":"Limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.xcrm.2023.101015_bib52","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2023.101015_bib53","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nmeth.2089","article-title":"NIH Image to ImageJ: 25 years of image analysis","volume":"9","author":"Schneider","year":"2012","journal-title":"Nat. Methods"},{"key":"10.1016\/j.xcrm.2023.101015_bib54","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/nmeth.3317","article-title":"HISAT: a fast spliced aligner with low memory requirements","volume":"12","author":"Kim","year":"2015","journal-title":"Nat. Methods"},{"key":"10.1016\/j.xcrm.2023.101015_bib55","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/bioinformatics\/btt656","article-title":"featureCounts: an efficient general\u00a0purpose program for assigning sequence reads to genomic features","volume":"30","author":"Liao","year":"2014","journal-title":"Bioinformatics"},{"key":"10.1016\/j.xcrm.2023.101015_bib56","doi-asserted-by":"crossref","first-page":"8543","DOI":"10.1074\/jbc.RA118.006983","article-title":"NOTCH signaling is activated in and contributes to resistance in enzalutamide-resistant prostate cancer cells","volume":"294","author":"Farah","year":"2019","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.xcrm.2023.101015_bib57","doi-asserted-by":"crossref","first-page":"3939","DOI":"10.1038\/s41388-020-1270-z","article-title":"p300\/CBP inhibition enhances the efficacy of programmed death-ligand 1 blockade treatment in prostate cancer","volume":"39","author":"Liu","year":"2020","journal-title":"Oncogene"}],"container-title":["Cell Reports Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379123001258?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379123001258?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T08:15:17Z","timestamp":1778919317000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666379123001258"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":57,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["S2666379123001258"],"URL":"https:\/\/doi.org\/10.1016\/j.xcrm.2023.101015","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-1450886\/v1","asserted-by":"object"}]},"ISSN":["2666-3791"],"issn-type":[{"value":"2666-3791","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A kinome-wide CRISPR screen identifies CK1\u03b1 as a target to overcome enzalutamide resistance of prostate cancer","name":"articletitle","label":"Article Title"},{"value":"Cell Reports Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xcrm.2023.101015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s).","name":"copyright","label":"Copyright"}],"article-number":"101015"}}